(3,5-dichlorophenyl)methyl 4-[(6-hydroxy-1-oxo-3,4-dihydro-2H-naphthalen-2-yl)methyl]piperazine-1-carboxylate
C23H24Cl2N2O4 — CID 152873710
Data last refreshed: (MolForge compound catalog, from PubChem)
About (3,5-dichlorophenyl)methyl 4-[(6-hydroxy-1-oxo-3,4-dihydro-2H-naphthalen-2-yl)methyl]piperazine-1-carboxylate
(3,5-dichlorophenyl)methyl 4-[(6-hydroxy-1-oxo-3,4-dihydro-2H-naphthalen-2-yl)methyl]piperazine-1-carboxylate (PubChem CID 152873710) has the molecular formula C23H24Cl2N2O4 and a molecular weight of 463.36 g/mol. Its IUPAC name is (3,5-dichlorophenyl)methyl 4-[(6-hydroxy-1-oxo-3,4-dihydro-2H-naphthalen-2-yl)methyl]piperazine-1-carboxylate.
Molecular Properties
| Compound Name | (3,5-dichlorophenyl)methyl 4-[(6-hydroxy-1-oxo-3,4-dihydro-2H-naphthalen-2-yl)methyl]piperazine-1-carboxylate |
|---|---|
| PubChem CID | 152873710 |
| Molecular Formula | C23H24Cl2N2O4 |
| Molecular Weight | 463.36 g/mol |
| Exact Mass | 462.11 |
| IUPAC Name | (3,5-dichlorophenyl)methyl 4-[(6-hydroxy-1-oxo-3,4-dihydro-2H-naphthalen-2-yl)methyl]piperazine-1-carboxylate |
| SMILES | O=C1c2ccc(O)cc2CCC1CN1CCN(C(=O)OCc2cc(Cl)cc(Cl)c2)CC1 |
| InChI | InChI=1S/C23H24Cl2N2O4/c24-18-9-15(10-19(25)12-18)14-31-23(30)27-7-5-26(6-8-27)13-17-2-1-16-11-20(28)3-4-21(16)22(17)29/h3-4,9-12,17,28H,1-2,5-8,13-14H2 |
| InChIKey | TZXFNHPFOOVPSX-UHFFFAOYSA-N |
| XLogP | 4.40 |
| TPSA | 70.08 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 31 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 463.36 |
| LogP ≤ 5 | 4.40 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 152873710 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.